DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to ...
MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.
Rarer diabetes patients in Singapore can now receive up to 80% government subsidies for continuous glucose monitoring (CGM) ...
Senseonics earns a buy with Eversense 365 driving growth, Q3 revenue up 90% YoY, gross margin expansion, and Ascensia ...
Given the vomiting and diarrhea, the biggest risk with norovirus is dehydration, which can turn a short-term illness into a ...
With the MetroCard retiring at the end of 2025, the OMNY system will become the only way to pay for most transit riders.
Mortality rates are high in patients with type 1 diabetes, and overweight and obesity appear to be major factors, a speaker ...
Our study assessed the impact of using Control-IQ technology, an automated insulin delivery system, on achievement of a Healthcare Effectiveness Data and Information Set (HEDIS) quality measure ...
Learn how the general depreciation system (GDS) works within MACRS, its methods, tax implications, and how it accelerates asset depreciation.
Learn how Electronic Benefits Transfer (EBT) works, its uses in government assistance programs like SNAP, and how it aids ...
Two leading lights in Galway and Mayo have joined forces – coming together to drive growth of seaweed-based animal nutrition.
Explore MiniMed Group, Inc.'s upcoming IPO, market position in diabetes devices, and key financial risks. Click for this MMED ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results